My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 363

    1.

    Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients.

    Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L.

    Crit Care. 2003 Oct;7(5):R78-83. Epub 2003 Jul 28.PMID: 12974973 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.

    Markou N, Markantonis SL, Dimitrakis E, Panidis D, Boutzouka E, Karatzas S, Rafailidis P, Apostolakos H, Baltopoulos G.

    Clin Ther. 2008 Jan;30(1):143-51.PMID: 18343250 [PubMed - indexed for MEDLINE]Related articles

    3.

    Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

    Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME.

    Clin Microbiol Infect. 2005 Feb;11(2):115-21.PMID: 15679485 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pseudomonas aeruginosa susceptible only to colistin in intensive care unit patients.

    Mastoraki A, Douka E, Kriaras I, Stravopodis G, Manoli H, Geroulanos S.

    Surg Infect (Larchmt). 2008 Apr;9(2):153-60.PMID: 18426347 [PubMed - indexed for MEDLINE]Related articles

    5.

    Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

    Kasiakou SK, Michalopoulos A, Soteriades ES, Samonis G, Sermaides GJ, Falagas ME.

    Antimicrob Agents Chemother. 2005 Aug;49(8):3136-46.PMID: 16048915 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.

    Michalopoulos A, Fotakis D, Virtzili S, Vletsas C, Raftopoulou S, Mastora Z, Falagas ME.

    Respir Med. 2008 Mar;102(3):407-12. Epub 2007 Dec 3.PMID: 18060758 [PubMed - indexed for MEDLINE]Related articles

    7.

    Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.

    Motaouakkil S, Charra B, Hachimi A, Nejmi H, Benslama A, Elmdaghri N, Belabbes H, Benbachir M.

    J Infect. 2006 Oct;53(4):274-8. Epub 2006 Jan 25.PMID: 16442632 [PubMed - indexed for MEDLINE]Related articles

    8.

    Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.

    Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME.

    Crit Care. 2005 Feb;9(1):R53-9. Epub 2005 Jan 6.PMID: 15693967 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.

    Falagas ME, Sideri G, Vouloumanou EK, Papadatos JH, Kafetzis DA.

    Pediatr Infect Dis J. 2009 Feb;28(2):123-7.PMID: 19116601 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.

    Falagas ME, Kasiakou SK, Kofteridis DP, Roditakis G, Samonis G.

    Eur J Clin Microbiol Infect Dis. 2006 Sep;25(9):596-9.PMID: 16955249 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population.

    Goverman J, Weber JM, Keaney TJ, Sheridan RL.

    J Burn Care Res. 2007 May-Jun;28(3):421-6.PMID: 17438490 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.

    Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V.

    Int J Infect Dis. 2007 Sep;11(5):402-6. Epub 2007 Feb 8.PMID: 17291803 [PubMed - indexed for MEDLINE]Related articles

    13.

    Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.

    Trottier V, Namias N, Pust DG, Nuwayhid Z, Manning R, Marttos AC Jr, Dunham MB, Schulman CI, McKenney MG.

    Surg Infect (Larchmt). 2007 Aug;8(4):437-43.PMID: 17883360 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Intravenous colistin in the treatment of infections due to pan-resistant Gram negative bacilli]

    Fica C A, Céspedes J I, Gompertz G M, Jalón V M, Sakurada Z A, Sáez L E.

    Rev Chilena Infectol. 2007 Oct;24(5):360-7. Epub 2007 Oct 26. Spanish. PMID: 17989839 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.

    Ghannam DE, Rodriguez GH, Raad II, Safdar A.

    Eur J Clin Microbiol Infect Dis. 2009 Mar;28(3):253-9. Epub 2008 Aug 28.PMID: 18752007 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

    Pintado V, San Miguel LG, Grill F, Mejía B, Cobo J, Fortún J, Martín-Dávila P, Moreno S.

    J Infect. 2008 Mar;56(3):185-90. Epub 2008 Feb 15.PMID: 18280570 [PubMed - indexed for MEDLINE]Related articles

    17.

    In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.

    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.

    Int J Antimicrob Agents. 2006 Mar;27(3):224-8. Epub 2006 Feb 7.PMID: 16464562 [PubMed - indexed for MEDLINE]Related articles

    18.

    Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study.

    Matthaiou DK, Michalopoulos A, Rafailidis PI, Karageorgopoulos DE, Papaioannou V, Ntani G, Samonis G, Falagas ME.

    Crit Care Med. 2008 Mar;36(3):807-11. Erratum in: Crit Care Med. 2008 Jul;36(7):2224. PMID: 18431267 [PubMed - indexed for MEDLINE]Related articles

    19.

    The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.

    Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A.

    Clin Med Res. 2006 Jun;4(2):138-46. Review.PMID: 16809407 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.

    Bassetti M, Repetto E, Righi E, Boni S, Diverio M, Molinari MP, Mussap M, Artioli S, Ansaldi F, Durando P, Orengo G, Bobbio Pallavicini F, Viscoli C.

    J Antimicrob Chemother. 2008 Feb;61(2):417-20. Epub 2008 Jan 3.PMID: 18174197 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity